search again

Nationwide rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $676,083 · 10th–90th $0$1,513,5610%20%10th90th$676,083Professionalmedian $562,341 · 10th–90th $549,541$707,9460%50%10th90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $977,237.22 / $1,584,893.19
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $707,945.78
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.03 / $660,693.45
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $707,945.78
Cigna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$691,830.97 / $1,548,816.62 / $2,041,737.94
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $616,595.00 / $676,082.98
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $870,963.59
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$346,736.85 / $524,807.46 / $741,310.24